Insider filing · TMDX

Waleed H Hassanein bought $2.0M of TransMedics (TMDX)

Executed Aug 6 2025, disclosed Aug 8 2025, 2 days later.

Over the 21 trading sessions from the disclosed entry session (Aug 8 2025), the stock returned -8.6% (delay-adjusted); from the execution session (Aug 6 2025), -16.7%. Derived: entry at the session's open, exit at the close 20 sessions later.

WH Waleed H Hassanein President & CEO profile →

Waleed H Hassanein (President & CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in TransMedics Group, Inc. (TMDX). Across 1 priced purchase filing, the average 21-session return was +9.2% from execution and +9.0% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of TMDX (8,775 sh × $114.00, as filed), executed Nov 17 2025.

TMDX TransMedics Group, Inc. TMDX · Healthcare · 21 filings in 24 months ticker →

Healthcare · TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage orga…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→